OLIGODENDROGLIOMA
Clinical trials for OLIGODENDROGLIOMA explained in plain language.
Never miss a new study
Get alerted when new OLIGODENDROGLIOMA trials appear
Sign up with your email to follow new studies for OLIGODENDROGLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo tested in fight against recurrent brain cancer
Disease control OngoingThis early-stage study is testing the safety and initial effects of combining two drugs, vorasidenib and pembrolizumab, in adults with a recurrent or worsening type of brain tumor called glioma. The goal is to see if this combination can help control the cancer by boosting the im…
Matched conditions: OLIGODENDROGLIOMA
Phase: PHASE1 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for kids with aggressive brain cancer: experimental stem cell therapy trial opens
Disease control OngoingThis early-stage trial is testing whether a combination of specially prepared stem cells and an immunotherapy drug (nivolumab) can help children and young adults with aggressive brain tumors that have returned after standard treatment. The study involves 12 participants aged 4-26…
Matched conditions: OLIGODENDROGLIOMA
Phase: PHASE1 • Sponsor: University of Florida • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
Scientists weaponize cold sore virus to fight deadly brain tumors
Disease control OngoingThis is a first-in-human safety study testing a genetically engineered virus, rQNestin34.5v.2, as a potential treatment for recurrent malignant brain tumors (gliomas). The virus is designed to infect and kill only cancer cells while sparing healthy brain tissue. The main goals ar…
Matched conditions: OLIGODENDROGLIOMA
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC